ABCG2 and breast carcinoma: Among the DETs, we found significant modulation of ABC transporters, including upregulation of multidrug exporter by 8.08-fold, pleiotropic drug resistance (5.58-fold), breast cancer resistance (9.0-fold) and lipid exporter proteins (7.23-fold).